Skip to main content
. Author manuscript; available in PMC: 2022 Sep 8.
Published in final edited form as: Cancer. 2018 Oct 5;124(23):4477–4485. doi: 10.1002/cncr.31705

TABLE 1.

Baseline Characteristics of Study Cohort Stratified by Treatment and Observation Groups

Group
All
N = 1800
Observation
N = 315
Treatment
N = 1485
P a
Mean age at diagnosis (SD), y 73.6 (8.2) 74.1 (8.6) 73.5 (8.2) .29
Male sex, no. (%) 1418 (78.8) 248 (78.7) 1170 (78.8) .98
White race/ethnicity, no. (%) 1757 (97.6) 312 (99.1) 1445 (97.3) .07
Health system, no. (%)
 Geisinger 938 (52.1) 243 (77.1) 695 (46.8) <.01
 Kaiser Permanente Northwest 862 (47.9) 72 (22.9) 790 (53.2)
Obese BMI, no. (%) 594 (33.0) 80 (25.4) 514 (34.6) <.01
Smoking status, no. (%)
 Current/former smoker 1322 (73.4) 219 (69.5) 1103 (74.3) <.01
 Never smoker 435 (24.2) 71 (22.5) 364 (24.5)
 Never assessed/unknown if ever smoked 43 (2.4) 25 (7.9) 18 (1.2)
Multiple chronic conditions at baseline: yes, no. (%) 1204 (66.9) 159 (50.5) 1045 (70.4) <.01
AJCC stage of disease/grade, no. (%)
 0A/low grade 921 (51.2) 216 (68.6) 705 (47.5) <.01
 0A/high grade 318 (17.7) 22 (7.0) 296 (19.9)
 0IS/high grade 92 (5.1) 16 (5.1) 76 (5.1)
 I/high grade 451 (25.1) 60 (19.0) 391 (26.3)
 Unknown 18 (1.0) 1 (0.32) 17 (1.1)
Alive status within 10 y of index date, no. (%) 1075 (59.7) 143 (45.4) 932 (62.8) <.01

Abbreviations: AJCC, American Joint Committee on Cancer; BMI, body mass index; SD, standard deviation.

a

Comparing the treatment and observation groups.